Background: This study sought to explore whether intervening in suspected cases of opioid overdose alters interest in treatment for opioid use disorder (OUD). Data were collected as a part of a trial comparing the effects of different overdose education and naloxone distribution (OEND) training curricula on overdose outcomes. Methods: Following OEND training, participants completed four in-person follow-up visits at 1-, 3-, 6- and 12-months. Participants were also regularly contacted to inquire about overdose events they responded to, witnessed, or experienced themselves. Other assessments included the Addiction Severity Index that queries participants' perceived importance of drug treatment on a scale of: 0 (Not at All) to 4 (Extremely). For the current secondary data analysis, treatment importance was assessed at the time points most immediately preceding and following participant intervention in an overdose event using naloxone. Results: The sample reported a mean duration of opioid use of 14.9 (± 11.5) years, with 67% having witnessed an overdose event prior to the study. Of the 321 enrolled, 92 participants used naloxone in response to 166 suspected cases of an opioid overdose. For the entire sample, mean treatment importance did not significantly change throughout the study. Among participants who utilized naloxone, treatment importance increased following the event (Before: 3.03, After: 3.39, p = 0.02). Due to the amount of time between the overdose event and assessment of post-event treatment importance (40.5 days, ±40.2), the current study most likely underestimates this effect. Conclusions: The current study suggests that responding to an overdose event increases interest in OUD treatment. Currently only considered an acute intervention to reduce overdose morbidity and mortality, OEND may have the potential to increase enrollment in medications to treat OUD. However, a prospective investigation needs to determine if the impact of an overdose event could be utilized to increase treatment engagement.
Background: This study sought to explore whether intervening in suspected cases of opioid overdose alters interest in treatment for opioid use disorder (OUD). Data were collected as a part of a trial comparing the effects of different overdose education and naloxone distribution (OEND) training curricula on overdose outcomes. Methods: Following OEND training, participants completed four in-person follow-up visits at 1-, 3-, 6- and 12-months. Participants were also regularly contacted to inquire about overdose events they responded to, witnessed, or experienced themselves. Other assessments included the Addiction Severity Index that queries participants' perceived importance of drug treatment on a scale of: 0 (Not at All) to 4 (Extremely). For the current secondary data analysis, treatment importance was assessed at the time points most immediately preceding and following participant intervention in an overdose event using naloxone. Results: The sample reported a mean duration of opioid use of 14.9 (± 11.5) years, with 67% having witnessed an overdose event prior to the study. Of the 321 enrolled, 92 participants used naloxone in response to 166 suspected cases of an opioid overdose. For the entire sample, mean treatment importance did not significantly change throughout the study. Among participants who utilized naloxone, treatment importance increased following the event (Before: 3.03, After: 3.39, p = 0.02). Due to the amount of time between the overdose event and assessment of post-event treatment importance (40.5 days, ±40.2), the current study most likely underestimates this effect. Conclusions: The current study suggests that responding to an overdose event increases interest in OUD treatment. Currently only considered an acute intervention to reduce overdose morbidity and mortality, OEND may have the potential to increase enrollment in medications to treat OUD. However, a prospective investigation needs to determine if the impact of an overdose event could be utilized to increase treatment engagement.
Entities:
Keywords:
Overdose; heroin; naloxone; opioid use disorder
Authors: Stephen Parkin; Joanne Neale; Caral Brown; Aimee N C Campbell; Felipe Castillo; Jermaine D Jones; John Strang; Sandra D Comer Journal: Int J Drug Policy Date: 2020-04-15
Authors: Maya Doe-Simkins; Emily Quinn; Ziming Xuan; Amy Sorensen-Alawad; Holly Hackman; Al Ozonoff; Alexander Y Walley Journal: BMC Public Health Date: 2014-04-01 Impact factor: 3.295
Authors: Alexander Y Walley; Ziming Xuan; H Holly Hackman; Emily Quinn; Maya Doe-Simkins; Amy Sorensen-Alawad; Sarah Ruiz; Al Ozonoff Journal: BMJ Date: 2013-01-30
Authors: Jermaine D Jones; Aimee N Campbell; Laura Brandt; Verena E Metz; Suky Martinez; Melanie Wall; Thomas Corbeil; Howard Andrews; Felipe Castillo; Joanne Neale; John Strang; Stephen Ross; Sandra D Comer Journal: Drug Alcohol Depend Date: 2022-05-23 Impact factor: 4.852
Authors: Suky Martinez; Jermaine D Jones; Laura Brandt; Denise Hien; Aimee N C Campbell; Sarai Batchelder; Sandra D Comer Journal: Drug Alcohol Depend Date: 2021-02-16 Impact factor: 4.492
Authors: Laura Brandt; Aimee N C Campbell; Jermaine D Jones; Suky Martinez; Joanne Neale; Stephen Parkin; Caral Brown; John Strang; Sandra D Comer Journal: Subst Abus Date: 2021-09-14 Impact factor: 3.716
Authors: Ian R H Rockett; Eric D Caine; Aniruddha Banerjee; Bina Ali; Ted Miller; Hilary S Connery; Vijay O Lulla; Kurt B Nolte; G Luke Larkin; Steven Stack; Brian Hendricks; R Kathryn McHugh; Franklin M M White; Shelly F Greenfield; Amy S B Bohnert; Jeralynn S Cossman; Gail D'Onofrio; Lewis S Nelson; Paul S Nestadt; James H Berry; Haomiao Jia Journal: EClinicalMedicine Date: 2021-02-08